声明：市场有风险，投资需谨慎。本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 2026年1月26日，兴业银锡（sz000426）触及涨停，涨停价63.67元，涨幅10%，总市值1130.55亿元，流 通市值1130.27亿元，截止发稿，总成交额14.40亿元。 根据喜娜AI异动分析，兴业银锡涨停原因可能如下，资源并购+业绩增长+控股股东重整： 1、公司完成 对宇邦矿业85%股权和大西洋锡业100%股权收购，增强了资源储备，国际化资源布局稳步推进。这有 助于提升公司的长期竞争力和可持续发展能力，为未来业绩增长奠定基础。 2、2025年1 - 9月公司营收 40.99亿元，同比增长24.36%，净利润13.64亿元，同比增长4.94%，三季度业绩实现稳健增长。经营活 动现金流净额2 ...

Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company's core business shows stable growth, driven by both R&D and restructuring efforts [8] - In 2024, the company achieved total revenue of 25.435 billion yuan, a year-on-year increase of 3.71%, while the net profit attributable to shareholders was 1.330 billion yuan, a decrease of 37.70% [8] - The company is focusing on core products and accelerating R&D innovation, with over 500 projects in the pipeline, including more than 60 innovative drug projects [8] Financial Performance Summary - Total revenue forecast for 2024 is 25.435 billion yuan, with a projected growth rate of 3.71% [8] - The net profit attributable to shareholders is expected to be 1.330 billion yuan in 2024, with a significant decrease of 37.70% [8] - The earnings per share (EPS) for 2024 is projected at 0.81 yuan, with a P/E ratio of 25.56 [8] - The company’s R&D expenses for 2024 are estimated at 1.471 billion yuan, reflecting a slight increase of 0.59% [8] - The company’s core anesthetic business is expected to grow steadily, with net profit forecasts for 2025 and 2026 adjusted to 2.224 billion yuan and 2.653 billion yuan, respectively [8]